2018
DOI: 10.1515/iss-2018-0005
|View full text |Cite
|
Sign up to set email alerts
|

Recent developments in cell-based ENS regeneration – a short review

Abstract: Therapeutic options to treat neurogenic motility disorders of the gastrointestinal tract are usually limited to symptomatic treatment. The capacity of the enteric nervous system (ENS) to regenerate and the fact that progenitor cells of the enteric nervous system reside in the postnatal and adult gut led to the idea to develop cellbased strategies to treat ENS related disorders. This short review focuses on recent developments in cell-based ENS regeneration, discussing advantages and disadvantages of various ce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 50 publications
(72 reference statements)
0
6
0
Order By: Relevance
“…In mammalian HSCR models a lot of progress has been made in optimizing transplantation therapy. However, there are still several limitations to overcome such as, limited migration of transplanted cells along the gut, requirement of very high numbers of cells and the integration in the endogenous ENS network [reviewed in: Obermayr and Seitz ( 2018 )]. Combining transplantation with the addition of chemical compounds that stimulate ENS development or make the ENS environment more favorable, could significantly improve transplantation outcomes (Lui et al, 2018 ; Zhao et al, 2020 ).…”
Section: Identification Of Drugs That Stimulate Ens Developmentmentioning
confidence: 99%
“…In mammalian HSCR models a lot of progress has been made in optimizing transplantation therapy. However, there are still several limitations to overcome such as, limited migration of transplanted cells along the gut, requirement of very high numbers of cells and the integration in the endogenous ENS network [reviewed in: Obermayr and Seitz ( 2018 )]. Combining transplantation with the addition of chemical compounds that stimulate ENS development or make the ENS environment more favorable, could significantly improve transplantation outcomes (Lui et al, 2018 ; Zhao et al, 2020 ).…”
Section: Identification Of Drugs That Stimulate Ens Developmentmentioning
confidence: 99%
“…However, this raises a question; what is the best source of these ENCCs? Depending on the source of ENCCs, they may be iPSC, ESCs, or native ENCCs [29]. To avoid use immunosuppression, the use of autologous-derived ENCCs would be the desired approach clinically.…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, before dwelling into those issues, we first must outline the therapeutic scheme that HSCR research tries to implement. The envisaged therapeutic approaches could be categorized according to the source of ENCC: induced pluripotent stem cell (iPSC), embryonic stem cell (ESC), or native ENCC [38]. In the iPSC-derived ENCC implantation method (Fig.…”
Section: Approaches and Cell Sourcementioning
confidence: 99%
“…The envisaged therapeutic approaches could be categorized according to the source of ENCC: induced pluripotent stem cell (iPSC), embryonic stem cell (ESC), or native ENCC [ 38 ]. In the iPSC-derived ENCC implantation method (Fig.…”
Section: Cell-based Therapymentioning
confidence: 99%
See 1 more Smart Citation